Somatostatinoma is a rare pancreatic endocrine tumor. First-line management requires structured evaluation of the patient's clinical and technical eligibility before a treatment path is defined.
This protocol covers first-line management of somatostatinoma arising from the pancreas, where both technical operability and the patient's overall medical condition determine which intervention is appropriate.
When the clinical and technical circumstances allow it, management is directed toward a surgical approach targeting the pancreatic tumor with curative intent. Patient-specific factors govern whether and how this option is pursued — the complete structured regimen is available in the full protocol.